• The Sox2+ esophagus and Nkx2-1+ trachea arise from the separation of a single foregut tube through a series of cellular events conserved in mouse and Xenopus
INTRODUCTION
Between 25-35 days of human gestation, the fetal gut tube separates into the distinct trachea and esophagus (Billmyre et al., 2015; Que, 2015) . Disruptions in this process result in lifethreatening defects that impair neonatal respiration and feeding, including esophageal atresia (EA), tracheal atresia (TA), and/or tracheoesophageal fistula (TEF) (Brosens et al., 2014) . The etiology of TEDs, occurring in ~1:3500 births, is poorly understood (Shaw-Smith, 2006) . Even when patient genetics or animal models have revealed the genes involved, how mutations result in TEDs is unclear because the cellular basis of TE morphogenesis are poorly defined.
Studies in mouse and Xenopus have shown that TE development is initiated by a signaling cascade involving HH, WNT and other signals between the foregut endoderm and the surrounding splanchnic mesoderm. These signals pattern the epithelium into a ventral respiratory domain expressing the transcription factor Nkx2-1 and a dorsal esophageal domain expressing the transcription factor Sox2 around mouse embryonic day (E) 9.0 and Xenopus NF35, 50 hours post fertilization (hpf) (Hines and Sun, 2014; Rankin et al., 2016) . Over the next few days, the foregut separates into distinct TE tubes, with paired lung buds emerging from the posterior aspect of the Nkx2-1+ domain via an Fgf10-mediated mechanism that is distinct from TE separation (Hines and Sun, 2014) . Mouse mutations in these patterning genes can result in TEDs similar to those seen in patients. For example, Sox2 and Nkx2-1 knockouts result in EA and TA, respectively (Minoo et al., 1999; Que et al., 2007; Trisno et al., 2018) , while HH pathway mutations, such as in the ligand Shh or the transcription factors Gli2 and Gli3, can cause a spectrum of defects ranging from EA/TEF to laryngotracheoesophageal clefts (LTECs) (Litingtung et al., 1998; Motoyama et al., 1998; Rankin et al., 2016; Tabler et al., 2017) . How these mutations result in TEDs is unclear since the cellular processes that HH regulates in this context are unknown. While a number of models for TE morphogenesis have been postulated (Billmyre et al., 2015; Que, 2015) , the underlying cellular mechanisms remain to be elucidated.
Here we use Xenopus and mouse to define the conserved cellular mechanisms orchestrating TE morphogenesis. We show that HH/Gli signaling regulates multiple steps of TE separation, including dorsal-ventral (D-V) patterning, medial constriction and endosomemediated epithelial remodeling. These results provide a mechanistic foundation for TE morphogenesis to inform the genotype-phenotype basis of human TEDs.
RESULTS and DISCUSSION

TE Morphogenesis is Conserved in Xenopus and Mouse
To define the cell biology of TE morphogenesis, we took a comparative approach using mouse and Xenopus. TE development appears to be conserved with patterning of the foregut epithelium into Sox2+ dorsal and Nkx2-1+ ventral domains by NF35 in Xenopus and E9.5 in mouse. The foregut then separates into distinct TE tubes by NF42 (80 hpf) in Xenopus and E11.5 in mice (Figures 1A-C' and S1A-F') (Rankin et al., 2015) . Close examination of Xenopus embryos over the course of TE morphogenesis allowed us to classify the process into four major steps: 1) D-V patterning; 2) medial constriction at the Sox2-Nkx2-1 boundary; 3) epithelial fusion and remodeling of a transient septum; and 4) mesenchymal invasion separating the TE tubes. We investigated the cellular basis of each step, first using Xenopus where we could screen many potential mechanisms, followed by a comparison to mouse.
Foxf1+ Mesenchyme Promotes Medial Constriction at the Sox2-Nkx2-1 Boundary
In Xenopus, the first morphological indication of TE separation was a medial constriction of the foregut at the Sox2-Nkx2-1 boundary by NF35, with a significant narrowing of the gut tube lumen coincident with thickening of the medial Foxf1+ splanchnic mesoderm ( Figure 1D ).
Analysis of transgenic membrane-GFP embryos revealed that the mesoderm thickening was not due to increased mesodermal cell size or cell shape changes, but rather to a condensation of Foxf1+ mesodermal cells ( Figures 1E and S1K ). This was accompanied by the epithelium transitioning from a thick pseudostratified layer at NF34 to a thinner columnar epithelium at NF35 ( Figure 1E ). Phospho-Histone H3 staining indicated that the medial mesenchyme had a slightly higher proliferation rate than the dorsal or ventral regions, which may in part explain the localized increase in mesenchymal cell numbers ( Figure S1G ,H).
The mouse foregut also constricted at the Sox2-Nkx2-1 boundary between E9.5 and E10.0 ( Figure 1F ), but there was no relative increase in medial mesoderm thickness, cell density or proliferation compared to the ventral or dorsal tissue as observed in Xenopus (Figures 1G, . In general, the mesoderm in mouse is much thicker than in Xenopus; however, in both species the Foxf1+ cells were more tightly packed against the epithelium at the constriction point (Figures 1A-F and S1I), suggesting a close association of the mesenchyme with the basement membrane in this region.
Since foregut constriction occurs at the Sox2-Nkx2-1 boundary, we re-examined mouse Nkx2-1 and Sox2 mutants where the TE does not separate, but the underlying mechanisms have not been reported. Both Nkx2-1 and Sox2 mutants failed to undergo medial constriction ( Figure 1I ), indicating that proper D-V patterning and the function of these two lineagedetermining transcription factors are essential to initiate TE morphogenesis. We postulate that the Sox2-Nkx2-1 boundary might also have some inherent information that regulates local mesenchyme behavior. These data help explain why human SOX2 mutations frequently cause EA; if the SOX2+ domain is too small, foregut constriction may not occur or might initiate too dorsally, resulting in insufficient esophageal tissue.
Since mesenchymal condensations can promote bending of adjacent epithelial sheets in some contexts (Walton et al., 2012) , we tested whether the mesoderm was required for medial constriction of the Xenopus gut tube by surgically removing the splanchnic mesenchyme from one side of the NF32 foregut. Imaging at NF35 revealed a failure of medial constriction and epithelial thinning relative to the contralateral control side ( Figure 1J ), suggesting that the mesoderm is required for medial constriction, possibly by exerting a pushing force on the epithelium. Together, these data indicate that medial constriction of the foregut at the Sox2-Nkx2-1 boundary is the critical first step in TE morphogenesis ( Figure 1K ) and that disruptions in this process can lead to TEDs.
Rab11 and Endosome-Mediated Epithelial Remodeling are Required for TE Septation
As the foregut constricts, the opposing epithelial walls come into contact, forming a transient epithelial septum (Figures 2A-C) . Close examination revealed a unique cell population in the septum that co-expresses Nkx2-1 and Sox2 (Figures 2D and S2A) . We examined whether modulators of epithelial behavior were differentially active at the Sox2+/Nkx2-1+ contact point.
Before collapse of the medial lumen, the endoderm is a polarized epithelium with aPKC on the apical/luminal surface and Cdh1 enriched in adherens junctions and on the basolateral surface.
As the epithelial walls touched, aPKC was specifically reduced at the contact point ( Figure 2B Remodeling of polarized epithelium is regulated by endosome recycling, where aPKC and cadherins are removed from the cell surface by endocytosis and shuttled to other membrane domains (Ivanov et al., 2004; Wang et al., 2018) . Immunostaining for endosomal protein Rab11 revealed abundant apical puncta where the epithelium fuses in both Xenopus and in mouse, coincident with loss of aPKC and Cdh1 relocalization ( Figure 2E -F). To test whether endosome recycling is required for TE separation, we treated Xenopus embryos at NF32 with Dynasore, a dynamin inhibitor that blocks endocytosis (Macia et al., 2006) . In Dynasore-treated embryos, aPKC remained aberrantly localized on the apical surface of the epithelial contact site at NF41, resulting in a tracheoesophageal cleft (TEC) at NF44 ( Figure 2G -I).
To corroborate the pharmacological inhibition, we performed F0 CRISPR/Cas9-mediated indel mutation of rab11a in Xenopus (Methods), as well as Rab11a knockdown with a wellcharacterized Rab11a antisense morpholino oligo (MO) (Kim et al., 2012) . All of these resulted in 25-30% of the embryos having gastrulation defects, as expected (Kim et al., 2012; Ossipova et al., 2015) ; however ~50% of the remaining embryos (which were grossly normal) exhibited a TEC at NF42-43 with a failure of the transient epithelial septum to resolve (Figures 2I, J and S2E) . In the case of rab11a-CRISPRs and Rab11a-MO, immunostaining confirmed the reduced Rab11 protein ( Figure S2B ). Finally, to overcome the earlier role of Rab11 in gastrulation, we generated transgenic Xenopus embryos expressing a dominant negative Rab11 in the foregut upon induction with doxycycline [Tg(hhex:trTA;TRE:dnRab11a-GFP)]. These also resulted in a TEC with enrichment of the dnRab11a-GFP on the basal-lateral epithelium rather than the normal apical surface ( Figure S2C -E). Together, these data demonstrate that Rab11adependent endosome-mediated epithelial remodeling is essential for the foregut walls to fuse properly and that disruptions in this process can lead to TEDs.
Localized ECM Degradation and Mesenchymal Invasion Resolve the TE Septum
Between NF40-42 in Xenopus and E10.5-11.5 in mice, the length of the Sox2-Nkx2-1 boundary decreased as the length of the separated trachea and esophagus increased ( Figure 3A ). The presumptive trachea and esophagus had comparable proliferation in both species (data not shown), indicating that differential growth is unlikely to account for TE separation (Ioannides et al., 2010) . This is consistent with a "splitting and extension" model (Que, 2015) , where active septation occurs along with relatively equal growth of the separated trachea and esophagus. We evaluated the possibility that the septum cells undergo apoptosis. Cleaved caspase-3 staining revealed a few dying cells in the resolving mouse septum ( Figure S3G ) (Ioannides et al., 2010) , but little septum cell death in Xenopus (data not shown). Rather, when the septum cells lost adhesion to one another, they appeared to incorporate into the esophageal or tracheal epithelium. This is consistent with reports in the companion paper (Kim et. al, 2019) and our observation that, immediately after TE separation in both Xenopus and mouse, it is not uncommon to see Nkx2-1+ cells in the ventral esophagus and Sox2+ cells in the dorsal trachea ( Figure S1E ). Thus, in both Xenopus and mouse, the transient septum is resolved by epithelial remodeling, localized ECM degradation, and mesenchymal cell invasion to separate the foregut into a distinct esophagus and trachea ( Figure S3H ). Disruption of this process at any point along the anterior-posterior axis could result in a TEF.
HH/Gli Activity is Required for D-V Patterning, Medial Constriction and Epithelial
Remodeling
Having defined the cellular events controlling TE morphogenesis, we next asked how disruptions in the HH signaling pathway cause TEDs. HH ligands are expressed in the foregut epithelium and signal to the mesoderm to activate Gli2 and Gli3 (Ioannides et al., 2003; Rankin et al., 2016) . In the absence of a HH signal, Gli2 is degraded and Gli3 is proteolytically cleaved into a transcriptional repressor (Gli3R). When the HH pathway is activated, Gli2 and Gli3 become transcriptional activators (Briscoe and Therond, 2013) . Multiple human TEDs have been associated with mutations in SHH, GLI2, and GLI3, including heterozygous truncating mutations in GLI3 (Johnston et al., 2005) .
We examined an allelic series of HH/Gli mouse mutants to determine which steps in TE morphogenesis were disrupted. Consistent with previous reports (Litingtung et al., 1998) , Shh -/embryos exhibited TA with a single hypomorphic gut tube at E15.5 ( Figure 4A ). Gli2 -/-;Gli3 +/mutants also failed to undergo TE separation, displaying a TEC along the length of the foregut ( Figure 4A ) (Motoyama et al., 1998) . In contrast, Gli2 +/-;Gli3 -/-, Gli3 -/and Gli2 -/-( Figure 4A and data not shown) mutants were indistinguishable from wildtype littermates, indicating a qualitative difference in Gli2 and Gli3, with a single copy of Gli2 being sufficient to support TE morphogenesis. We also examined transgenic embryos ectopically expressing a truncated repressor form of Gli3 (Vokes et al., 2008) in the foregut mesendoderm (Foxg1Cre;Gli3T), which mimics the GLI3 mutation in Pallister-Hall Syndrome (PHS) [Online Mendelian Inheritance in Man 151560] (Johnston et al., 2005) . Like PHS patients, Foxg1;Gli3T embryos had LTECs ( Figure 4A ). These results indicate that increasing levels of Gli3R relative to Gli activator cause increasing severity of TEDs.
To understand the cellular basis of these defects ( Figure 4B ), we examined earlier developmental stages. At E10.0, Gli2 -/-;Gli3 -/embryos, which lack all HH activity, failed to undergo D-V patterning, with no Nkx2-1+ respiratory progenitors and very little Foxf1+ mesenchyme (Rankin et al., 2016 ) ( Figure 4C ). In contrast, the foregut was properly patterned in all other genotypes with ventral Nkx2-1 and dorsal Sox2, although the Shh -/foregut was smaller with fewer Nkx2-1+ and Foxf1+ cells. Although Shh -/mutants were correctly patterned, they failed to medially constrict, similar to NF37 Xenopus embryos treated with HH antagonist cyclopamine ( Figures 4C and S4B ). Unlike Shh -/mutants, Gli2 -/-;Gli3 +/embryos had normal levels of Foxf1+ mesenchyme and initiated medial constriction. Foxg1Cre;Gli3T embryos also exhibited medial constriction, although these had fewer Foxf1+ cells in the ventral region ( Figure   4C ). These data show that high levels of HH activity are needed for D-V patterning, medial constriction and to maintain sufficient Foxf1+ mesoderm, consistent with Foxf1 being a direct Gli transcriptional target (Mahlapuu et al., 2001) .
We next assessed Gli2 -/-;Gli3 +/and Foxg1Cre;Gli3T mutants at E11.0 for defects in epithelial remodeling and septation ( Figure 4D ). In Gli2 -/-;Gli3 +/mutants the foregut lumen remained open, suggesting that although medial constriction was initiated, the process was insufficient to bring the epithelial walls into contact. Alternatively, disrupted epithelial remodeling might result in failure of cell adhesion at the constriction point, followed by a relaxation and a TEC. Indeed, in Foxg1Cre;Gli3T embryos, aPKC and Rab11 persisted at the anterior contact point where the epithelium touched but failed to fuse, whereas in wild type embryos aPKC, Rab11 and Cdh1 were rapidly downregulated as the opposite walls of the epithelium fused ( Figure 4F ). This was similar to Xenopus embryos with disrupted endosome recycling, suggesting that the LTEC was caused by impaired epithelial remodeling in the septum.
Gli3 MO knockdown in X. laevis and CRISPR/Cas9-mediated gli3 mutation in X.
tropicalis resulted in phenotypes similar to Gli2 -/-;Gli3 +/and Foxg1Cre;Gli3T mouse mutants, with a delay in medial constriction and failure of TE separation resulting in TECs ( Figure S4 ). In most cases, the transient septum formed but failed to resolve, with the lumen eventually reopening to form a cleft. CRISPR-mediated indel mutations of the gli3 C-terminus, predicted to result in a Gli3R form like the PHS patient mutation, resulted in persistent aPKC in the septum, like Foxg1Cre;Gli3T mouse embryos. Immunostaining of Gli3 MO X. laevis embryos showed a mislocalization of Rab11, which is normally enriched at the point of apical membrane fusion ( Figure 4E ). These results collectively indicate that HH/Gli-regulated epithelial remodeling is required for TE morphogenesis in both Xenopus and mouse, and that this is compromised in Gli3 mutant models of PHS.
Conclusion
We have defined the conserved HH/Gli-regulated cellular mechanisms orchestrating TE morphogenesis: 1) D-V foregut patterning; 2) mesenchymal medial constriction at the Sox2-Nkx2-1 boundary; 3) epithelial fusion of cells co-expressing Sox2 and Nkx2-1 to form a transient septum; and 4) Rab11-dependent endosome-mediated epithelial remodeling and localized ECM breakdown to resolve the septum. Importantly, these results provide a cellular explanation for the previous models of TE separation. The data also help explain the genotype-phenotype association of TEDs in patients with SHH and GLI mutations, as a greater loss of HH activity causes earlier and more severe TE morphogenesis disruptions. Complete loss of HH/Gli results in TA, while one copy of Gli3 appears to be sufficient to support D-V patterning and constriction, but not septation, resulting in a TEC. We predict that partial or transient disruption in epithelial remodeling would result in an interruption in progressive septation and a TEF. Our data also suggest that a balance between Gli activator and repressor function is critical, with excessive Gli3R resulting in TEDs. Further studies will focus on identifying mesenchymal Gli targets and how these regulate epithelial remodeling and TE morphogenesis. Candidates include proteins that modulate cell adhesion, endosome-mediated epithelial remodeling, and ECM degradation.
Consistent with this prediction, human TEDs have been linked to mutations in Integrin Alpha 6 (ITGA6), Filamin A (FLNA), and Fraser extracellular matrix subunit 1 (FRAS1) (Brosens et al., 2014) .
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There are no conflicts of interest to declare. S1A-C: Wholemount confocal immunostaining of Sox2, Nkx2-1 and Foxf1 in X. laevis (A-B) and mouse (C-D) foregut epithelium. Surface renderings and optical sections show conserved TE morphogenesis, with Sox2+ dorsal foregut giving rise to esophageal epithelium and Nkx2-1+ central foregut giving rise to tracheal and lung epithelium. After separation, rare Sox2+/Nkx2-1+ cells are observed in the ventral esophagus and dorsal trachea (arrowhead in D'). S1E, F: Alcian blue cartilage staining shows similar tracheal differentiation in Xenopus (E) and mouse (F). e = esophagus, t = trachea, lg = laryngeal groove S1G: Immunostaining of phospho-histone H3-positive (pHH3+) cells, marking proliferating cells in NF34.5 X. laevis. S1H: Quantification of S1G. Endo = (pHH3+Cdh1+)/Cdh1+ cells, meso = (pHH3+Foxf1+)/Foxf1+ cells. The mitotic indices of the medial X. laevis endoderm and mesoderm are higher than those seen in the corresponding dorsal and ventral areas. Student's two-tailed t-test, *p<0.05. S1I: Immunostaining of pHH3, Foxf1 and Cdh1 in mouse E10.0 foregut. S1J: Quantification of S1G, showing no statistically significant difference in pHH3+/Foxf1+ mesoderm cell proliferation from different regions. Two-way ANOVA, *p<0.05. S1K: Size and shape of Xenopus mesoderm cells. Average circularity, length/width ratio, and cell area (within .1µm 2 ) of NF34 and NF35 foregut mesoderm show no statistical difference between regions. Mixed-effects analysis, *p<0.05. S1L: Size and shape of mouse mesoderm cells. Average circularity, length/width ratio, and cell area (within .1µm 2 ) of E9.5, E10.0 and E10.5 foregut mesoderm show no statistical difference between regions. Mixed-effects analysis, *p<0.05. S2D: Sequential optical sections from wholemount immunostaining of transgenic Tg(hhex:rtTA; TRE:dnRab11a-GFP) X. laevis embryos at NF42-43. Addition of doxycycline (dox) from NF32-43 resulted in the expression of a dominant-negative Rab11a specifically in the hhex+ foregut, which caused a failure of TE septation and a persistent TEC similar to Rab11 knockdown. GFP shows that the dnRab11a protein inappropriately localized to the basal-lateral surface compared to the localization of wildtype Rab11 at the apical surface and fusion point (Fig. 2SD ). This confirms that Rab11 is specifically required for TE separation, independent of possible prior requirements for Rab11 during gastrulation. Scale bar, 100 µm. S2E: Summary of TEC frequencies in experiments that block Rab11-dependent endosomemediated epithelial remodeling in X. laevis embryos. Supplemental Figure S4 (Related to Figure 4 ) HH Signaling and Gli3 are Required for TE Morphogenesis in Xenopus S4A: Immunostaining of Nkx2-1, Cdh1 and Foxf1 in NF42 X. laevis embryos injected with previously validated control MOs, Gli2 MOs or Gli3 MOs (5-7 ng) (Rankin et al 2016) or treated with the HH antagonist cyclopamine. Gli2 MO embryos show no defect, while Gli3 MO and Gli2+Gli3 MO fail to septate and exhibit a TE cleft. This suggests that gli3 plays a more critical role than gli2 during X. laevis TE separation. Note higher doses of Gli2+Gli3 MO (10 ng each) fail to pattern the foregut and induce Nkx2-1 as previously shown (Rankin et al 2016) .
Supplemental
Supplemental Figure S3 (Related to Figure 3) Resolution of the Epithelial Septum
S4B: Immunostaining of Nkx2-1, Sox2 and Foxf1 in NF35 X. laevis embryos treated with cyclopamine exhibit delayed medial constriction as indicated by the yellow arrows and reduced Foxf1+ mesenchyme, but preserve dorsal-ventral patterning, similar to Shh-/-mutant mice (Figure 4) . S4C: Immunostaining of Nkx2-1, Sox2 and Foxf1 in NF35 X. laevis embryos injected with control MOs or Gli3 MOs, showing delayed medial constriction in Gli3 morphants. S4D: Schematic of human and Xenopus Gli3 proteins and the truncating mutation that results in Pallister Hall Syndrome (PHS). Summary of targeting strategy for CRISPR/Cas9-mediated indel mutagenesis of X. tropicalis gli3 in embryos. Mutation of gli3 exon 2 is predicted to result in loss of function (LOF) mutants whereas gli3R PHS mutants are predicted to maintain Gli3 transcriptional repressor activity. S4E-G. Immunostaining of Sox2, Foxf1 and Nkx2-1 in control (E) and CRISPR-mediated F0 mutant X. tropicalis embryos at NF41. gli3 LOF mutants (F) and gli3R mutants (G) fail to septate and exhibit a persistent TEC, similar to Gli3 MO X. laevis embryos. S4H-J: Immunostaining of Cdh3, Foxf1 and aPKC in control (H) and CRISPR-mediated F0 mutant X. tropicalis embryos at NF41. gli3 LOF mutants (I) show an abnormally thick TE septum that fails to resolve, whereas gli3R PHS mutants show persistent aPKC in the septum (arrow), similar to the Foxg1Cre;Gli3T mouse mutants, indicating that excessive Gli3R activity prevents remodeling of apical-basal epithelium polarity in the septum and prevents septation. S4K: Summary of the TED phenotypes in Xenopus embryos with disrupted HH/Gli3 activity. The F0 CRISPR/Cas9 mutagenesis results in embryos with mosaic mutations. The average percentage of damaging indel mutations from sequencing-TIDE genotyping (see methods) is shown.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Xenopus and all mouse lines described here were housed at Cincinnati Children's Hospital Medical Center (CCHMC) and maintained according to the NIH Guidelines for the Care and Use of Laboratory Animals. All animals were housed in a 12-hour light-dark cycle with standard chow, and only healthy animals were used for experiments. Both mouse and Xenopus embryos were collected to analyze tracheoesophageal morphogenesis, and the sex of embryos was not recorded. All experiments were performed using guidelines approved by the CCHMC Institutional Animal Care and Use Committee (IACUC2019-0006 and IACUC2016-0059).
METHOD DETAILS
Experimental Design
All Xenopus experiments were performed at least three times. In the case of mouse mutants, at least three mouse mutants, age-matched by somite number if collected at E11.5 or earlier, were used for analysis in each experiment. Sample size and animal sex were not deliberately determined. For most of the analysis samples were not blinded except the determination of TEC phenotypes in Xenopus embryos, which were scored blind. No data was excluded from analysis.
Xenopus experiments
Xenopus laevis and Xenopus tropicalis were purchased from Nasco or the National Xenopus Resource Center (X. laevis memGFP) and housed according to established CCHMC IACUC protocols. X. tropicalis "Superman" animals were generously provided by Mustafa Khokha (Yale University). Generation of Xenopus embryos was performed using ovulation and in vitro fertilization techniques previously described.
For X. laevis microsurgery experiments the ectoderm and lateral plate mesoderm surrounding the foregut were removed from one side of NF32/33 embryos and cultured in 0.5XMBS with gentamicin until NF35 when they were fixed along with unmanipulated siblings.
For morpholino (MO) knockdowns we injected previously validated Gli3-MOs (5 ng), Gli2-MO (5 ng) (Rankin et al., 2016) and Rab11a-MO (50 ng) (Kim et al., 2012) , or equal concentrations of standard control morpholinos, into the dorsal-ventral region of 2-8 cell stage X. laevis embryos to target the future foregut region.
For transient F0 mosaic CRISPR/Cas9 mutagenesis, guide RNAs (gRNAs) were designed using CRISPRScan or CHOPCHOP and synthesized by IDT. For gli2 and gli3 loss of function, gRNAs targeting the X. tropicalis gli2 exon 4 or gli3 exon 2 were designed to produce truncating indels or missense mutations resulting in premature stop codon prior to the DNAbinding domains. A gRNA targeting the X. tropicalis gli3 in exon13 corresponding to the human Pallister Hall Syndrome GLI3 d699 mutation was designed such that a premature stop codon would prevent translation of the Gli3 activator domain resulting in a constitutive repressor form.
For the rab11a LOF mutations, we designed gRNAs targeting a region in exon 2 that has identical sequence identity between and X. tropicalis rab11a and X. laevis rab11a.S (X.laevis rab11a.L has a 2-nucleotide mismatch and is predicted not to be targeted). X. laevis embryos were used for rab11a CRISPR/Cas9 mutagenesis because the Rab11 antibodies (to verify loss of Rab11) work in laevis but not tropicalis. RNA-seq data in Xenbase.org indicated that rab11a.S transcripts are expressed two-fold higher than rab11a.L in X. laevis tadpoles.
Consistent with the mRNA levels, Rab11 immunofluorescence showed that rab11a.S CRISPR mutants (with wildtype rab11a.L), have dramatically reduced Rab11a protein levels ( Figure   S2B ). To generate F0 mosaic gli2, gli3, gli3R and rab11a.S mutant embryos, the gRNAs (750 pg) were then injected with Cas9 protein (1-1.5 ng; PNA Biosciences) into X. tropicalis or X.
laevis embryos at the one-cell stage or the eight-cell stage targeted to the foregut endoderm.
For negative controls, tyrosinase (tyr) gRNAs were injected. These resulted in a high frequency of F0 embryos lacking pigment indicating effective indel mutations, but no detectable TED.
To genotype embryos, genomic DNA was extracted from tails and the genomic regions target by the gRNAs were PCR amplified with 2X Phusion Master Mix (Thermo Fisher Scientific F531) according to manufacturer's instructions. Successful indel mutation was initially verified with a T7E1 (New England BioLabs Incorporated M0302S) digest of the PCR product, followed by, Sanger sequencing. Overall efficiency and allele frequency of specific mutations were determined by TIDE sequencing decomposition analyses (https://tide.deskgen.com). The table below shows the efficiency of truncating indel mutations for each gRNA.
Gene, exon (species)
Damaging indel %, n gli2 exon 4 (X. tropicalis) 57% (n=7) gli3 exon 2 (X. tropicalis) 36% (n=25) gli3 exon 13 PHS (X. tropicalis) 50% (n=27) rab11a.S exon 2 (X. laevis) 78% (n=16)
For small molecule treatments, Xenopus laevis embryos were cultured at room temperature, covered in aluminum foil, in 0.1XMBS in the presence of small molecules that were refreshed once every 12-24 hours beginning at NF28/29-32/33. Control sibling embryos were treated with equal volumes of the small molecule solvent (e.g., EtOH or DMSO). Small molecule treatment concentrations were: cyclopamine (Selleck or Tocris, 80µM), Dynasore (Millipore Sigma, 50µM), GM6001 (Millipore Sigma, 150µM) and 1,10-phenanthroline (Millipore Sigma, 5 µM).
For Xenopus transgenesis, the I-SceI meganuclease method was used as described (Sterner et al., 2019) . The Tg(hhex;rtTA;TRE:dnRab11a-GFP) construct was generated as follows. The -1.2Kb X.laevis hhex.L promoter (Rankin et al., 2011) and the dNRab11a-GFP fusion coding sequence (Kim et al., 2012) were PCR amplified gel purified and TOPO-TA cloned into the pCR8 Gateway entry vectors (Thermo Scientific #K250020). Gateway LR Clonase II Plus enzyme (Thermo Scientific #12538120) was used in standard recombination reactions according to manufacturer's instructions to transfer the hhex.L promoter into the pDXTP and dNRab11-GFP into the pDXTR transgenesis plasmids (Sterner et al., 2019) .
Transgenic embryos were generated as follows: 200pg of pDXTP-hhex promoter and 200pg of pDXTR-dNRab11-GFP were incubate in a 25uL reaction containing 2.5uL of I-SceI meganuclease enzyme (New England Biolabs #R0694S) in 0.5X I-SceI buffer. The reaction was incubated at 37 0 C for 30 to 40 minutes and then immediately injected into 1-cell embryos near the sperm entry point within the first 45 to 60 minutes after fertilization. Embryos were cultured at 13 0 C for the first two hours after injection and subsequently at 18 0 C to 23 0 C degrees thereafter. Transgenic embryos were selected based on GFP fluorescence in the eye, which becomes visible during early tailbud stages (Sterner et al., 2019) . In half of the embryos the transgenes were activated by the addition of Doxycycline hyclate (Sigma #D9891) at a final concentration of 50ug/mL culture buffer. The addition of Dox alone has no effect on the embryos and did not cause TEDs.
All of the confocal analysis in Xenopus embryos was performed in wholemount.
Embryos were cut transversely just anterior to the pharynx and posterior to the lung buds in 100% MeOH. After serial rehydrations into 1XPBS with 0.1% Triton X-100 (1XPBSTr) 
